未经证实:肺动脉(PA)和升主动脉(AA)直径的比值最近被证明是肺动脉高压和心力衰竭患者疾病严重程度和预后预测指标的有用指标。这项研究旨在评估该比率在接受肺动脉内膜切除术的慢性血栓栓塞性肺动脉高压患者围手术期风险评估中的适用性。
UNASSIGNED:在对2013年至2020年期间接受肺内膜切除术的149例患者进行的这项回顾性队列研究中,在轴向计算机断层扫描上分析了术前PA与AA的比率。在术前右心导管插入术和术后Swan-Ganz导管测量期间评估了肺血流动力学状态的变化。采用Kaplan-Meier法和log-rank检验分析围手术期生存率。
UNASSIGNED:术前计算机断层扫描测量显示中位AA直径为31毫米(范围,19-47毫米),PA的中值直径为36毫米(范围,25-55毫米)。计算的PA与AA的中值比率为1.13(范围,0.79-1.80)。PA与AA比值与PA压呈正相关(收缩压,r=0.352[P<.001];舒张压,r=0.406[P<.001];平均值,r=0.318[P<.001]),与年龄成反比(r=-0.484[P<.001])。单变量Cox回归分析确定PA直径(P=.008)作为预测生存的术前参数。PA与AA比率较低的患者的30天生存概率存在显着差异(log-rankP=0.037)(<1.136;生存概率,97.4%)与比例较高的患者相比(>1.136;生存概率,88.9%)。
UNASSIGNED:PA与AA的比率显示出与肺动脉高压相关的其他变量的相关性。此外,PA/AA比值较高的患者接受PEA治疗后生存概率较低.进一步分析PA与AA比值对慢性血栓栓塞性肺动脉高压不同治疗方式的选择——肺内膜剥脱术,医学治疗,和或球囊肺血管成形术-是必要的。
UNASSIGNED: The ratio of pulmonary artery (PA) and ascending aorta (AA) diameters has recently been shown to be a useful indicator for disease severity and predictor of outcome in patients with pulmonary hypertension and heart failure. This study aimed at evaluating the applicability of this ratio for perioperative risk assessment of patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy.
UNASSIGNED: In this retrospective cohort study on 149 patients undergoing pulmonary endarterectomy between 2013 and 2020, the preoperative PA to AA ratio was analyzed on axial computed tomography. Variables of pulmonary hemodynamic status were assessed during preoperative right heart catheterization and postoperative Swan-Ganz catheter measurements. Perioperative survival was analyzed by Kaplan-Meier method and log-rank tests.
UNASSIGNED: Preoperative computed tomography measurements showed a median AA diameter of 31 mm (range, 19-47 mm), and a median PA diameter of 36 mm (range, 25-55 mm). The calculated median PA to AA ratio was 1.13 (range, 0.79-1.80). PA to AA ratio correlated positively with PA pressure (systolic, r = 0.352 [P < .001]; diastolic, r = 0.406 [P < .001]; mean, r = 0.318 [P < .001]) and inversely with age (r = -0.484 [P < .001]). Univariable Cox regression analysis identified PA diameter (P = .008) as a preoperative parameter predictive of survival. There was a significant difference (log-rank P = .037) in 30-day survival probability for patients with lower PA to AA ratios (<1.136; survival probability, 97.4%) compared with patients with higher ratios (>1.136; survival probability, 88.9%).
UNASSIGNED: PA to AA ratio shows a correlation with other variables associated with pulmonary hypertension. In addition, patients with higher PA to AA ratios have lower survival probabilities after PEA. Further analysis of PA to AA ratio on the selection of chronic thromboembolic pulmonary hypertension for different treatment modalities-pulmonary endarterectomy, medical therapy, and or balloon pulmonary angioplasty-is warranted.